GNTA
Price
$1.79
Change
-$0.20 (-10.05%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
41.94M
Intraday BUY SELL Signals
INBX
Price
$82.16
Change
+$4.57 (+5.89%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.19B
Intraday BUY SELL Signals
Interact to see
Advertisement

GNTA vs INBX

Header iconGNTA vs INBX Comparison
Open Charts GNTA vs INBXBanner chart's image
Genenta Science SpA
Price$1.79
Change-$0.20 (-10.05%)
Volume$3.63K
Capitalization41.94M
Inhibrx Biosciences
Price$82.16
Change+$4.57 (+5.89%)
Volume$1.57K
Capitalization1.19B
GNTA vs INBX Comparison Chart in %
GNTA
Daily Signal:
Gain/Loss:
INBX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GNTA vs. INBX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNTA is a Hold and INBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (GNTA: $1.79 vs. INBX: $82.14)
Brand notoriety: GNTA and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNTA: 14% vs. INBX: 96%
Market capitalization -- GNTA: $41.94M vs. INBX: $1.19B
GNTA [@Biotechnology] is valued at $41.94M. INBX’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNTA’s FA Score shows that 1 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • GNTA’s FA Score: 1 green, 4 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than GNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNTA’s TA Score shows that 3 TA indicator(s) are bullish while INBX’s TA Score has 4 bullish TA indicator(s).

  • GNTA’s TA Score: 3 bullish, 7 bearish.
  • INBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INBX is a better buy in the short-term than GNTA.

Price Growth

GNTA (@Biotechnology) experienced а -19.37% price change this week, while INBX (@Biotechnology) price change was +12.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($1.2B) has a higher market cap than GNTA($41.9M). INBX YTD gains are higher at: 433.377 vs. GNTA (-58.851).
GNTAINBXGNTA / INBX
Capitalization41.9M1.2B4%
EBITDAN/A-155.08M-
Gain YTD-58.851433.377-14%
P/E RatioN/A0.20-
RevenueN/A1.4M-
Total CashN/A187M-
Total DebtN/A107M-
TECHNICAL ANALYSIS
Technical Analysis
GNTAINBX
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GNTA
Daily Signal:
Gain/Loss:
INBX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLTTX12.65N/A
N/A
Wilshire International Equity Instl
AIGYX11.14N/A
N/A
abrdn Real Estate Fund Instl
JGEMX13.13N/A
N/A
JHancock Global Equity R6
JVAPX37.96-0.08
-0.21%
JPMorgan Value Advantage R3
BIERX27.44-0.19
-0.69%
Brandes International Equity R6

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with NEVPF. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+5.86%
NEVPF - INBX
59%
Loosely correlated
N/A
AXON - INBX
48%
Loosely correlated
-0.50%
AKESF - INBX
45%
Loosely correlated
+0.52%
SNTI - INBX
39%
Loosely correlated
+2.75%
VCYT - INBX
37%
Loosely correlated
+3.02%
More